Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$143,938
-$244,038 QoQ
Shares Held
10,263
+504.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3,993
of 4,153 holders
Holding Since
Jun 2021
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GFS Advisors, LLC holds $987,567 across 10 Drug Manufacturers - General names. ABBV ranks #4 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
300 | $359,829 | |
| 2 | NVO |
Novo Nordisk A S
|
5,840 | $279,969 | |
| 3 | JNJ |
Johnson & Johnson
|
46,182 | $143,960 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
10,263 | $143,938 | |
| 5 | GSK |
GSK plc
|
372 | $19,500 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,710 | $18,634 | |
| 7 | OGN |
Organon & Co.
|
1,267 | $17,155 | |
| 8 | MRK |
Merck & Co., Inc.
|
79,011 | $3,361 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $143,938 | 10,263 | Shares | Sole | 2026-08-04 | |
| 2025-12-31 | $387,976 | 1,698 | Shares | Sole | 2026-02-11 | |
| 2021-06-30 | $204,216 | 1,813 | Shares | Sole | 2021-07-26 | |
| No filing history on record for this holder in this stock. | ||||||